Regulatory News:
As per specifications set at Meda's 2011 annual general meeting, a nomination committee has been appointed. It consists of:
Karl-Magnus Sjölin, Committee Chairman, Stena Sessan Rederi AB
Bert Åke Eriksson, Meda's Chairman of the Board, Stena Sessan Rederi AB
Evert Carlsson, Swedbank Robur funds
Bengt Belfrage, Nordea's funds
Marcus Lüttgen, Alecta Pension Fund
MEDA AB (publ) is a leading international specialty pharma company. Meda's products are sold in 120 countries worldwide and the company is represented by its own organizations in 50 countries. The Meda share is listed under Large Cap on the Nasdaq OMX Nordic Stock Exchange in Stockholm. Find out more, visit www.meda.se.
This information was brought to you by Cision http://www.cisionwire.com
Contacts:
Karl-Magnus Sjölin, Committee Chairman
ph. +46 31-774 35 35
or
Anders
Larnholt, Vice President Corporate Development & IR
ph: +46
709-458 878
